関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Europium chloride, anhydrous 99.9% | HCID 9859933 | — |
| 反応物 | Levothyroxine Sodium | HCID 23666112 | — |
| 溶媒 | Ethanol | HCID 702 | — |
| 溶媒 | Dimethylformamide | HCID 6228 | — |
| 生成物 | Thyroxine | HCID 5819 | — |
反応手順
Fluorescent compound (v) synthesized in Example 4 was dissolved in dimethylformamide at a concentration of 5.0×10-5M, and thyroxine sodium salt was dissolved in ethanol at a concentration of 5.0×10-5M. The fluorescent compound (v) solution (100 μl) and the thyroxine sodium salt solution (100 μl) of ethanol were mixed and incubated for 30 minutes at room temperature with stirring. The resulting solution was subjected to a HPLC purification (column: AP-313, YMC Co., solvent: methanol: water=3:7(v:v) including 0.02% acetic acid) and the fluorescent compound (v)-labelled thyroxine was purified. The fluorescent compound (v)-labelled thyroxine was identified by measuring the thyroxine activity using an enzyme immunoassay (Boehringer Mannheim GmbH), and by measuring fluorescence intensity of the solution prepared by mixing equal volume of europium chloride (1×10-5M) and the fraction.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US05262526 |
|---|
| 出典データセット | uspto-grants-1993_11 |
|---|
| ORD ID | ord-47de7a514e3547679a0e2c8e966c64ef |
|---|
| 出典メモ | uspto-grants-1993_11 |
|---|